Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
Scan.com, which gives patients direct access to private medical imaging services, raises $12M

From TechCrunch

By Paul Sawers

April 16, 2023

Scan.com, which gives patients direct access to private medical imaging services, raises $12M

Scan.com, which gives patients direct access to private medical imaging services, raises $12M

Anyone in the U.K. who has tried to book an NHS medical appointment of late will know just how much of an ordeal it can be, with median waiting times for consultant-led elective care (i.e. pre-planned clinical treatment) currently sitting at around 14.6 weeks in England. This has led to a spike in people turning to the private medical sector, a trend some argue heralds the start of a two-tier healthcare system where those with financial means effectively pay to fast-track their treatment.

In tandem, a floundering public healthcare system has created fertile ground for healthtech startups to flourish, addressing everything from staffing shortages to improving radiologists’ tech stack.

One such company is Scan.com, a London-based medical imaging startup that connects patients with scanning centers, covering MRI, ultrasound, CT, and X-ray. The company today announced it has raised $12 million in a Series A round of funding, as it looks to build on its recent U.S. launch.

Waiting times

The problem, according to Scan.com, is that even if a patient is able to book a doctor’s appointment in the first place (a procedure that is becoming increasingly difficult in itself in the U.K.), the subsequent referral process to get an appropriate scan can take several months, after which they may have to wait even longer to receive the results.

Scan.com has partnered with hundreds of scanning centers to enable individuals to access medical imaging services with or without a GP’s referral, with user-friendly reports replete with clickable diagrams delivered within a week.

Scan.com report Image Credits: Scan.com

To use Scan.com’s online referral system, users pay up-front to secure their scan, and then they are booked in for a virtual consultation with a clinician within 48 hours.

Prices vary based on a number of factors such as location and the type of scan required, but rough ball-park figures run anywhere from £180 to £395 or more, and includes the consultation, the scan, and all the follow-on reports.

If a scan identifies a serious problem, the patient enters Scan.com’s “urgent findings pathway,” where a clinical team contacts the patient and their doctor to explain the results and offer guidance on what to do next.

But the ability to bypass a GP (general practitioner) and self-refer for a medical scan surely could lead to all manner of time-wasting endeavors — what if a patient doesn’t actually need a scan?

“Our clinical team offers consultations and guidance to all patients once they’ve booked, which is a core part of the service we offer,” Scan.com CEO Charlie Bullock explained to TechCrunch. “Their time is included in our scan pricing, which is why we take payment at the point of booking. During the consultation, the clinician can amend the scan type, add or amend body parts, and ensure the scan is both safe and medically justified for the patient’s needs.”

Bullock added that if the clinician determines that there is no justification for the scan, Scan.com refunds the full cost and provides guidance on what the patient should do next. “This happens in around 3% of cases,” Bullock said.

But most patients who are at the stage of thinking about scans are likely to have had some medical assessments already that suggest some a scan might be needed to get to the root of their problems, and a large chunk of the target user-base are simply looking to circumvent the lengthy waiting times currently encumbering the NHS.

“Patients may choose to self-refer for imaging for a variety of reasons, but one of the core factors is speed,” Bullock said. “Some patients may have already seen a GP, physiotherapist, or other healthcare provider, but have reached a bottleneck in their healthcare pathway due to long waiting times. They may know what scan they need, and in many cases have been informed of the waiting time, and they choose to come to us to access the next steps faster.”

Scan.com: Simple referrals

Scan.com: Simple referrals Image Credits: Scan.com

In truth, there are numerous scenarios that may require a service such as that provided by Scan.com. Some people might have general concerns and want a preventative screening without taking up the time of a primary healthcare provider, and Scan.com offers full-body MRI scans for such cases.

“Family history or lifestyle factors that could lead to disease can be investigated and checked in this way,” Bullock said.

Also, more than 10,000 women under the age of 50 are diagnosed with breast cancer in the U.K. each year, while the country’s national screening program only starts from the age of 50. As such, Scan.com is gearing up to launch early mammogram screenings later this year targeting women under the age of 50 specifically.

“We aim to fill that gap to speed up access to treatment,” Bullock added.

The story so far

Scan.com’s team of 30 Image Credits: Scan.com

Scan.com was founded some five years ago by clinicians Khalid Latief and Jasper Nissim who had grown exasperated by “inefficiencies” in organizing diagnostics for their patients. Launching initially as a side-project, the duo brought on board CEO Charlie Bullock, COO Oliver Knight, and front-end designer Joe Daniels as co-founders in 2019, bootstrapping their way through to 2021 before going full-time and raising some £4.2 million ($5.2 million) in seed funding from investors including Monzo co-founder Tom Blomfield.

Today, Scan.com claims around 30 employees across the U.K. and U.S., having launched its product Stateside two months ago.

“We ramped up to $1 million in annualised revenue in the first five weeks in the U.S. following this launch,” Bullock said.

So far, Scan.com has been piloting its service in Georgia, and the company is looking to expand to five more states to “cement ourselves as the leading diagnostic imaging platform in the U.S.,” Bullock said. “We also know there is significant opportunity within Europe, but with language barriers and more varied healthcare systems, our focus is the U.S. and U.K. for the time being.”

With another $12 million in the bank, Scan.com is well-financed to continue its U.S. expansion and also extend its service offering to include the likes of DEXA scans, echocardiograms, and the aforementioned mammograms, while also pursuing enterprise contracts across digital health providers, employee benefit platforms, among other industry organizations.

“Medical imaging covers such a variety of modalities that our focus is to launch as many of these as we can,” Bullock said. “Alongside scans, we also want to design pathways to add value for our patients, such as guided injections for pain relief, or adding in-vitro testing and pathology solutions to our preventative screenings to make them more comprehensive.”

Scan.com’s Series A round was co-led by Oxford Capital, Aviva Ventures, YZR Capital, Triple Point Ventures and Simplyhealth Ventures, with participation from Forefront Venture Partners.

Scan.com, which gives patients direct access to private medical imaging services, raises $12M by Paul Sawers originally published on TechCrunch

Most Recent

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Jul 20, 2026

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

The one-year-old startup aims to reinvent financial architecture for autonomous AI transactions.

Jul 20, 2026

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

AI infrastructure company Infinity announced Monday a $15 million raise at a $100 million valuation from investors including Touring Capital, Principal VC, and researchers from companies such as OpenAI and Anthropic.

Jul 20, 2026

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

For the first time since 2024, StrictlyVC is coming back to New York City — and we're bringing the kind of access you’d expect from an under-wraps event to the whole startup, VC, and dealmaking community.

Jul 20, 2026

Similar Posts

Oxford spinout RADiCAIT uses AI to make diagnostic imaging more affordable and accessible — catch it at TechCrunch Disrupt 2025

Oxford spinout RADiCAIT uses AI to make diagnostic imaging more affordable and accessible — catch it at TechCrunch Disrupt 2025

“What we really do is we took the most constrained, complex, and costly medical imaging solution in radiology, and we supplanted it with what is the most accessible, simple and affordable, which is CT,” Sean Walsh, RADiCAIT’s CEO told TechCrunch.

Oct 27, 2025

Hippocratic is building a large language model for healthcare

Hippocratic is building a large language model for healthcare

AI, specifically generative AI, has the potential to transform healthcare. At least, that sales pitch from Hippocratic Health, which emerged from stealth today with a whopping $50 million in seed financing behind it and a valuation in the “triple digit millions.” The tranche, co-led by General Catalyst and Andreessen Horowitz, is a big vote of […]

May 16, 2023

India’s HealthPlix raises $22M to accelerate growth and enhance healthcare delivery

India’s HealthPlix raises $22M to accelerate growth and enhance healthcare delivery

HealthPlix, an Indian startup offering its in-house platform for doctors to help record patient data digitally, has raised $22 million in fresh investment to broaden its reach in the country and allow more doctors to utilize its software to offer improved care to their patients. In India, roughly 300,000 doctors practice medicine regularly. However, this […]

Mar 14, 2023

India’s HealthPlix raises $22M to accelerate growth and enhance healthcare delivery

India’s HealthPlix raises $22M to accelerate growth and enhance healthcare delivery

HealthPlix, an Indian startup offering its in-house platform for doctors to help record patient data digitally, has raised $22 million in fresh investment to broaden its reach in the country and allow more doctors to utilize its software to offer improved care to their patients. In India, roughly 300,000 doctors practice medicine regularly. However, this […]

Mar 14, 2023

Most Recent

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Jul 20, 2026

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

The one-year-old startup aims to reinvent financial architecture for autonomous AI transactions.

Jul 20, 2026

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

AI infrastructure company Infinity announced Monday a $15 million raise at a $100 million valuation from investors including Touring Capital, Principal VC, and researchers from companies such as OpenAI and Anthropic.

Jul 20, 2026

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

For the first time since 2024, StrictlyVC is coming back to New York City — and we're bringing the kind of access you’d expect from an under-wraps event to the whole startup, VC, and dealmaking community.

Jul 20, 2026

Similar Posts

Oxford spinout RADiCAIT uses AI to make diagnostic imaging more affordable and accessible — catch it at TechCrunch Disrupt 2025

Oxford spinout RADiCAIT uses AI to make diagnostic imaging more affordable and accessible — catch it at TechCrunch Disrupt 2025

“What we really do is we took the most constrained, complex, and costly medical imaging solution in radiology, and we supplanted it with what is the most accessible, simple and affordable, which is CT,” Sean Walsh, RADiCAIT’s CEO told TechCrunch.

Oct 27, 2025

Hippocratic is building a large language model for healthcare

Hippocratic is building a large language model for healthcare

AI, specifically generative AI, has the potential to transform healthcare. At least, that sales pitch from Hippocratic Health, which emerged from stealth today with a whopping $50 million in seed financing behind it and a valuation in the “triple digit millions.” The tranche, co-led by General Catalyst and Andreessen Horowitz, is a big vote of […]

May 16, 2023

India’s HealthPlix raises $22M to accelerate growth and enhance healthcare delivery

India’s HealthPlix raises $22M to accelerate growth and enhance healthcare delivery

HealthPlix, an Indian startup offering its in-house platform for doctors to help record patient data digitally, has raised $22 million in fresh investment to broaden its reach in the country and allow more doctors to utilize its software to offer improved care to their patients. In India, roughly 300,000 doctors practice medicine regularly. However, this […]

Mar 14, 2023

India’s HealthPlix raises $22M to accelerate growth and enhance healthcare delivery

India’s HealthPlix raises $22M to accelerate growth and enhance healthcare delivery

HealthPlix, an Indian startup offering its in-house platform for doctors to help record patient data digitally, has raised $22 million in fresh investment to broaden its reach in the country and allow more doctors to utilize its software to offer improved care to their patients. In India, roughly 300,000 doctors practice medicine regularly. However, this […]

Mar 14, 2023